To improve our understanding of the patient-significance of differential DKK1 expression, we profiled DKK1 levels in 108 ER+ breast cancer patient plasma samples compared to 105 matched plasma controls from healthy women. The gene discussed is DKK1; the disease is breast carcinoma.